Sangamo Terminates Development of a Neuropathy Drug - Oct. 3, 2011

Having trouble viewing this email? View in Browser.

Monday, October 03, 2011  |   |   |   |  CHI's Ninth International Discovery on Target November 2-4, 2011 | Boston, MA www.DiscoveryOnTarget.com This fall Cambridge Healthtech Institute will host its Ninth International Discovery on Target event showcasing novel "hot" targets for the pharmaceutical industry November 2-4 in Boston, Massachusetts. Advance Registration Discounts are available. Don't miss this opportunity to take advantage of reduced registration rates and save up to $200! This is a must attend event to keep up with current and upcoming developments in target discovery and to collaborate and connect with experienced scientists and high level decision makers. Join us for in-depth coverage of novel drug targets focused on HDAC, RNAi, the PI3K pathways, allosteric modulators, metabolic pathways in tumor cells, kinase inhibitors, GPCR and Diabetes. To register and for up-to-date information, visit www.DiscoveryOnTarget.com •  Sangamo (SGMO) Terminates Development of a Neuropathy Drug More... More Discontinuations News More Recalls and Warning News •  Strides Arcolab Limited Subsidiary Onco Therapies Gets US FDA Approval for Paclitaxel Injection More... •  Sagent Pharmaceuticals, Inc. Announces FDA Approval of Clindamycin Injection, USP More... More Drug Approval News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS2 and the fee will be waived. All passes subject to approval. Register here today or call 800-390-4078. •  Ipsen's Partner, Inspiration Biopharmaceuticals, Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B and Will Receive $35 Million More... •  Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B More... •  ADVENTRX Pharmaceuticals Inc. (ANX) Announces Results of FDA Meeting to Discuss Exelbine NDA More... More BLA/NDA/ANDA News More IND News More MAA News •  Novartis AG (NVS)' Onbrez Beats Boehringer Ingelheim Corporation/Pfizer Inc. (PFE)'s Spiriva for COPD Quality of Life More... •  EntreMed, Inc. (ENMD)'s ENMD-2076 Demonstrates Promising Activity in a Phase 2 Study in Platinum-Resistant Ovarian Cancer Patients More... •  NuPathe Inc. (PATH) Reports Positive Top-Line Results from 12-Month, Repeat Use Safety Trial for its Migraine Patch More... •  Dynavax Technologies Corporation (DVAX) Reports Modified Intent to Treat Analysis From the HEPLISAV(TM) Phase 3 Trial in Healthy Adults Over Age 40 More... •  Auxilium Pharmaceuticals (AUXL) Announces First Patient Enrolled in XIAFLEX® Phase IIIb Dupuytren's Contracture Multicord Study More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers Request Now! •  Daily Aspirin Tied to Risk of Vision Loss, Netherlands Institute for Neuroscience Study More... •  Beta Blockers May Prevent Spread of Breast Cancer, Cancer Research UK Cambridge Research Institute Study More... •  Stress Hormones May Increase Cardiovascular Risks for Shift Workers, Erasmus MC Study More... •  Poor Footwear Linked to Foot Impairment and Disability in Gout Patients, Auckland University of Technology Study More... •  Multiple Surgeries and Anesthesia Exposure, Mayo Clinic Study More... More General Clinical Research News Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. • Pharm Country (Bridgewater, New Jersey) ImClone Systems Corporation Manager-Clinical Trials Directs the conduct of a clinical trial for phase I and/or II under supervision and/or supports the Trial Team Leader in the management of a clinical trial, by leading assigned activities and working packages. • Genetown (Cambridge, Massachusetts) Sanofi Clinical Trials Operations Manager Responsible for the overall operational planning and activities for the implementation and conduct of studies (clinical trials, observational trials, compassionate use and registries) including data management activities in compliance with GCP's, SOPs and standards within established timelines and budgets. • BioTechxus (San Antonio, Texas) Eagle Applied Sciences Research Clinical Scientist Will support all activities related directly and indirectly to the planning, development, and execution of clinical research and medical technology product development projects. Expert input on research proposals, protocols, and projects and/or activities related to clinical translational research efforts will be needed. • Biotech Bay (Oakland, California) Cerexa, Inc. Senior Administrative Assistant, Clinical Operations Responsible for the proactive support of administrative activities in Clinical Operations, with a focus on anticipating and providing administrative support to the Vice President of Clinical Operations and Clinical Operations staff. The position also includes responsibility to assist the organization with company activities, such as event planning and execution, receptionist relief, etc.; and leadership in ensuring that administrative support is collaborative, cross-functionally, across the company. • Bio NC (Durham, North Carolina) PAREXEL International Senior Biostatistician/ Principal Biostatistician, Clinical Trials Will be charged with the task of producing and delivering analysis plans, reports, derived datasets, tables, listings and figures, providing statistical advice to clients, and fulfilling the project primary role within a designated project team. Interact with clients as key contact with regard to statistical and contractual issues. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioMidwest Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Midwest region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Production and Manufacturing Processes for Its Long-acting Human Growth Hormone More... More Patent News •  Momenta Pharmaceuticals, Inc. (MNTA) Files for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. (WPI) and International Medical Systems, Ltd. to Halt Blood Thinner Launch More... •  The Medicines Company (MDCO) Launches New Formulation of Cleviprex(R) (Clevidipine) Injectable Emulsion More... More Drug Product News Hot Company Gallus Biopharmaceuticals, LLC 4766 LaGuardia Drive St. Louis, Missouri 63134 U.S.A. Phone: 314-426-5000 Fax: 314-426-1792 Gallus Biopharmaceuticals, LLC has recently emerged on the market as a premier cGMP biologics contract manufacturing organization based in St. Louis, MO USA. Gallus operates an FDA-approved, commercial facility formerly owned by Centocor Biologics. The plant has been approved by every major regulatory agency and currently manufactures two of Centocor Biologics' leading products, Remicade® and Stelara™, which are distributed globally. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.